In Depth 24 Oct 2017 Where to Find the Money to Get Your Biotech Startup Up with the Big Boys What do you need to kickstart your own biotech company? A great idea, of course. Industry knowledge, a plus. Money… This could be tricky. Breaking into the biotech industry is one of the most expensive decisions that you can make. First, you need ground-breaking science that has what it takes to change its respective field, […] October 24, 2017 - 8 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
In Depth 17 Oct 2017 Blockbuster Potential: How Biotech is Paving the Way to Clear Skin from Psoriasis Though the psoriasis market is teeming with effective products, companies have developed ways to devise new, more effective modes of treatment. Psoriasis is a common autoimmune disorder that affects the skin, often causing patches of dry, itchy, and painful lesions. In severe cases, people can develop psoriatic arthritis, which can lead to painful inflammation in […] October 17, 2017 - 7 minutesmins - By Diana Kwon Share WhatsApp Twitter Linkedin Email
In Depth 27 Sep 2017 How to Survive the Valley of Death: Tips from Europe’s Largest Research Hospital Taking research from the bench to the bedside is an infamous graveyard in biotech. Researchers from Charité and their colleagues have a plan to help startups survive. “Many basic research approaches currently fail far too late in their development,” write researchers from Charité University Hospital, based here in Berlin, in collaboration with colleagues from the University […] September 27, 2017 - 4 minutesmins - By Evelyn Warner Share WhatsApp Twitter Linkedin Email
In Depth 5 Sep 2017 The Next Generation of Genetic Medicine: A Review of Epigenetics The field of genetics has long been an object of global fascination, beginning with Mendel’s pea plant experiments in the 19th century and peaking when the human genome was sequenced (albeit not completely) in 2003. But epigenetics as the next level up from genetics is still mysterious to most. Efforts are already underway to make […] September 5, 2017 - 9 minutesmins - By Evelyn Warner Share WhatsApp Twitter Linkedin Email
In Depth 25 Jul 2017 Trouble in Paradise: How Biotech is Fighting Tropical Diseases Tropical diseases are often neglected until an outbreak causes worldwide panic. Here’s how European biotech is preparing for the next one. “What we really need is a very fast and cheap way to develop vaccines,” biotech godfather Greg Winter told me earlier this year. Such precautionary measures may well be on our minds as Europe […] July 25, 2017 - 6 minutesmins - By Evelyn Warner Share WhatsApp Twitter Linkedin Email
In Depth 20 Jul 2017 SHIVA Trial: France’s Big Shot at Precision Medicine for Cancer SHIVA01 and SHIVA02 are large-scale trials run in France to evaluate the efficacy of precision medicine that have created ripples in the oncology field. Although molecular alterations are shared among different types of cancer, drug development today is still mainly based on tumor localization. The only recent exception is MSD’s Keytruda (pembrolizumab) an antibody approved by […] July 20, 2017 - 5 minutesmins - By Timothé Cynober Share WhatsApp Twitter Linkedin Email
In Depth 19 Jul 2017 The Humanities of Scientific Investment: Perspectives from Europe’s Top Biotech Hub Deep human connections are the key to success in business, and biotech is no exception. The secret to amplifying this effect? Women. Commenting on the personal dimension of business usually comes as an aside in broader discussions, but at the ON Helix conference in the Cambridge area last Thursday, Sharon Vosmek, CEO of Silicon Valley-based […] July 19, 2017 - 4 minutesmins - By Evelyn Warner Share WhatsApp Twitter Linkedin Email
In Depth 12 Jul 2017 Genomic Testing in Oncology: From Single Genes to Whole Genomes Personalized medicine would be nothing without genomic testing tools. Here’s an overview of how the field has rapidly evolved in the past years. BRCA (BReast CAncer) is one of the most famous gene variants for breast cancer testing. But aside from being a game-changer from a scientific perspective, it also changed the laws of genomic testing. […] July 12, 2017 - 5 minutesmins - By Timothé Cynober Share WhatsApp Twitter Linkedin Email
In Depth 11 Jul 2017 Regenerating the Body With Stem Cells – Hype or Hope? When the Japanese researcher Shinya Yamanaka managed to reprogram adult cells into an embryonic-like state to yield induced pluripotent stem cells (iPSCs), this was supposed to herald a revolution in regenerative medicine. But 10 years after their discovery, a therapeutic breakthrough is still outstanding. “The overall stem cell therapy field has failed today to show […] July 11, 2017 - 9 minutesmins - By Melanie De Almeida Share WhatsApp Twitter Linkedin Email
In Depth 13 Jun 2017 Will Gene Editing Bypass the GMO Struggle or Worsen Public Distrust? In the US, the first CRISPR-edited crops were able to bypass GMO regulations, but Europe’s plant scientists are still awaiting the final go ahead. In April 2016, the US Department of Agriculture (USDA) gave the green light to the first CRISPR-edited crops, a mushroom that has been engineered to resist browning and a waxy corn from […] June 13, 2017 - 6 minutesmins - By Melanie De Almeida Share WhatsApp Twitter Linkedin Email
In Depth 24 May 2017 What Happens when the Immune System Attacks Life-Saving Drugs? Immunogenicity has been largely disregarded despite its huge impact on the performance of biological drugs. What is it and how can we fight it? Immunogenicity can be a huge problem. Affecting especially protein-based drugs, this process consists in the development of anti-drug antibodies (ADAs) against a molecule that, in most cases, is saving the life […] May 24, 2017 - 4 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
In Depth 10 May 2017 Incentivizing Charity: A New Way to Fund Cancer Research Here’s what we learned from a lecture by finance guru Roger Stein on a new cancer research funding model at the Charité BIH Entrepreneurship Summit in Berlin. “I’m not a scientist. I can’t build a drug. I’m never going to have enough money to fund even one of those [clinical] trials. But…all of us together […] May 10, 2017 - 4 minutesmins - By Evelyn Warner Share WhatsApp Twitter Linkedin Email